Tanner Pharma Group Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Tanner Pharma Group Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7563
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tanner Pharma Group Inc (Tanner Pharma), a subsidiary of Bourne Capital Partners LLC, is a pharmaceutical services company which offers distribution, licensing and commercialization of health care products. The company offers clinical trial sourcing solutions, regulatory affairs management and legal services, sales and marketing services, market access programs and analysis, pre-launch sales program design services. It also provides clinical trial logistics and inventory management for trials conducted by manufacturers, CRO’s and research centers in the US, Europe, Mexico and Brazil. Tanner Pharma offers licensing, acquisition and commercialization of products for pharmaceutical and biotech companies. The company operates in Europe, Northeast Asia, Southeast Asia, the Middle East, Australia, Canada and Latin America, including Brazil, Mexico, the Caribbean, Central America and all of South America. Tanner Pharma is headquartered in Charlotte, North Carolina, the US.

Tanner Pharma Group Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tanner Pharma Group Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tanner Pharma Group Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tanner Pharma Group Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tanner Pharma Group Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tanner Pharma Group Inc, Medical Devices Deals, 2012 to YTD 2018 9
Tanner Pharma Group Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Tanner Pharma Group Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
MannKind Enters into Distribution Agreement with Tanner Pharma 11
Tanner Pharma Enters into Distribution Agreement with Merz North America 12
Merger 13
Tanner Pharma Merges with BurnsAdler Pharma 13
Tanner Pharma Group Inc – Key Competitors 14
Tanner Pharma Group Inc – Key Employees 15
Tanner Pharma Group Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Tanner Pharma Group Inc, Pharmaceuticals & Healthcare, Key Facts 2
Tanner Pharma Group Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tanner Pharma Group Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tanner Pharma Group Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tanner Pharma Group Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Tanner Pharma Group Inc, Medical Devices Deals, 2012 to YTD 2018 9
Tanner Pharma Group Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
MannKind Enters into Distribution Agreement with Tanner Pharma 11
Tanner Pharma Enters into Distribution Agreement with Merz North America 12
Tanner Pharma Merges with BurnsAdler Pharma 13
Tanner Pharma Group Inc, Key Competitors 14
Tanner Pharma Group Inc, Key Employees 15
Tanner Pharma Group Inc, Other Locations 16

List of Figures
Tanner Pharma Group Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Tanner Pharma Group Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Tanner Pharma Group Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Tanner Pharma Group Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Tanner Pharma Group Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tanner Pharma Group Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Tanner Pharma Group Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tanner Pharma Group Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tanner Pharma Group Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Tanner Pharma Group Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kumagai Gumi Co Ltd (1861):企業の財務・戦略的SWOT分析
    Kumagai Gumi Co Ltd (1861) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • CIBC Wealth Management:企業の戦略・SWOT・財務情報
    CIBC Wealth Management - Strategy, SWOT and Corporate Finance Report Summary CIBC Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • CAS Medical Systems Inc (CASM):医療機器:M&Aディール及び事業提携情報
    Summary CAS Medical Systems Inc (CASMED) is a medical device company that designs, manufactures and markets technologies and monitors. The company offers technologies and monitors that deliver patient data. Its products comprise FORE-SIGHT absolute tissue oximeter, blood pressure measurement technol …
  • Grupa Zywiec S.A.:企業の戦略・SWOT・財務情報
    Grupa Zywiec S.A. - Strategy, SWOT and Corporate Finance Report Summary Grupa Zywiec S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Toshiba America Medical Systems Inc:製品パイプライン分析
    Summary Toshiba America Medical Systems Inc (TAMS), a subsidiary of Toshiba Medical Systems Corp, is a medical device company which markets and distributes the diagnostic imaging systems. The company offers cardiovascular X-ray, computed tomography, angiography, magnetic resonance, ultrasound and x- …
  • Aiphone Co Ltd (6718):企業の財務・戦略的SWOT分析
    Aiphone Co Ltd (6718) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Erasmus MC-製薬・医療分野:企業M&A・提携分析
    Summary Erasmus MC (Erasmus) is a medical institute that offers patient care, research and educational services. The institute offers graduate and doctoral programs in health sciences, biomedical sciences, molecular medicine and cardiovascular sciences. It conducts research in the areas of biochemis …
  • Immuron Ltd (IMC)-製薬・医療分野:企業M&A・提携分析
    Summary Immuron Ltd (Immuron), formerly Anadis Limited is a biopharmaceutical company that conducts research and develops polyclonal antibody products for humans. The company develops and produces an orally stable therapeutic for various immune mediated and inflammatory disorders. Immuron’s products …
  • High Peak Royalties Ltd (HPR):電力:M&Aディール及び事業提携情報
    Summary High Peak Royalties Limited (High Peak) is a leading utility company that builds a portfolio of diversified resource royalties with projects in exploration, pre-production and producing phases. It assesses a regular flow of potential royalty investments across the resources sector. The compa …
  • The New Zealand Refining Co Ltd (NZR):石油・ガス:M&Aディール及び事業提携情報
    Summary The New Zealand Refining Co Ltd. (Refining NZ) is an oil refining company that refines and distributes oil products. It operates an oil refinery at Marsden Point in Whangarei, New Zealand. The company processes crude oil types imported from offshore markets and produces refined petroleum pro …
  • ManTech International Corporation:企業の戦略・SWOT・財務情報
    ManTech International Corporation - Strategy, SWOT and Corporate Finance Report Summary ManTech International Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Raymond Ltd (RAYMOND EQ):企業の財務・戦略的SWOT分析
    Raymond Ltd (RAYMOND EQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Koninklijke Philips N.V. (PHIA):医療機器:M&Aディール及び事業提携情報
    Summary Koninklijke Philips N.V. (Philips) is a diversified technology company develops and manufactures medical systems, consumer electronics and lighting products. The company offers patient care & clinical informatics, imaging systems, healthcare transformation services and home healthcare soluti …
  • RPC Group PLC:企業のM&A・事業提携・投資動向
    RPC Group PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's RPC Group PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Orascom Construction Plc (OC):企業の財務・戦略的SWOT分析
    Orascom Construction Plc (OC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Nikkiso Co Ltd (6376):企業の財務・戦略的SWOT分析
    Nikkiso Co Ltd (6376) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Shangri-La Hotels (Malaysia) Berhad:企業の戦略・SWOT・財務情報
    Shangri-La Hotels (Malaysia) Berhad - Strategy, SWOT and Corporate Finance Report Summary Shangri-La Hotels (Malaysia) Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Clear Channel Outdoor Holdings Inc (CCO):企業の財務・戦略的SWOT分析
    Summary Clear Channel Outdoor Holdings Inc (Clear Channel), is an outdoor advertising company that provides creative services to smaller advertisers. The company offers services through traditional and digital display formats on roadside, urban, transit and airport environment. It also provides adve …
  • ASB Bank Limited:企業の戦略・SWOT・財務情報
    ASB Bank Limited - Strategy, SWOT and Corporate Finance Report Summary ASB Bank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Anavex Life Sciences Corp (AVXL):製薬・医療:M&Aディール及び事業提携情報
    Summary Anavex Life Sciences Corp (Anavex) is a clinical-stage biopharmaceutical company that focuses on developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, other central nervous system (CNS) diseases, pain and various types of cancer. The c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆